Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2016-08-04

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s00210-016-1279-6PMID 27492718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Healing mechanisms of the hydroalcoholic extract and ethyl acetate fraction of green tea (Camellia sinensis (L.) Kuntze) on chronic gastric ulcers

  2016cited by this paper
• Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats.

  2013cited by this paper
• Angiotensin II Induces C-Reactive Protein Expression via AT1-ROS-MAPK-NF-κB Signal Pathway in Hepatocytes

  2013influential reference
• C-reactive protein predicts short-term mortality in patients with cirrhosis.

  2012cited by this paper
• Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages

  2012cited by this paper
• Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages

  2012cited by this paper
• Pharmacological profile of green tea and its polyphenols: a review

  2012cited by this paper
• Rosiglitazone inhibits angiotensin II-induced C-reactive protein production in human aortic endothelial cells through regulating AT1–ROS–MAPK signal pathway

  2012cited by this paper
• Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages

  2012cited by this paper
• Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.

  2011influential reference
• The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis.

  2011cited by this paper
• Preventive Effects of (−)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice

  2011cited by this paper
• High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.

  2010cited by this paper
• Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.

  2010influential reference
• Epigallocatechin-3-gallate inhibits interleukin-6- and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells.

  2010cited by this paper
• Role of angiotensin II in liver fibrosis‐induced portal hypertension and therapeutic implications

  2010cited by this paper
• PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway

  2009cited by this paper
• Hepatotoxicity from green tea: a review of the literature and two unpublished cases

  2009cited by this paper
• Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.

  2008cited by this paper
• Inflammation and liver.

  2008cited by this paper
• Innate immune response and hepatic inflammation.

  2007cited by this paper
• Molecular mechanisms of aging-associated inflammation.

  2006cited by this paper
• Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

  2006cited by this paper
• [High-sensitivity C-reactive protein (hs-CRP): a promising biomarker for the screening of non-alcoholic steatohepatitis (NASH)].

  2006cited by this paper
• Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.

  2005cited by this paper
• Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune Encephalomyelitis1

  2004cited by this paper
• Inflammation as a Cardiovascular Risk Factor

  2004cited by this paper
• Effect of green tea catechins on oxidative DNA damage of hamster pancreas and liver induced by N‐Nitrosobis(2‐oxopropyl)amine and/or oxidized soybean oil

  2004cited by this paper
• Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.

  2003influential reference
• Proceedings of the Third International Scientific Symposium on Tea and Human Health: Role of Flavonoids in the Diet Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal Studies

  2003influential reference
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells.

  2003influential reference
• The Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate Blocks Nuclear Factor-κB Activation by Inhibiting IκB Kinase Activity in the Intestinal Epithelial Cell Line IEC-6

  2001cited by this paper
• The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6.

  2001cited by this paper

• The medicinal value of tea drinking in the management of COVID-19

  2023cites this paper
• Causal relationship between tea intake and cardiovascular diseases: A Mendelian randomization study

  2022cites this paper
• Coffee and Green Tea Consumption and Cardiovascular Disease Mortality Among People With and Without Hypertension

  2022cites this paper
• Green Tea and Coffee Consumption and All-Cause Mortality Among Persons With and Without Stroke or Myocardial Infarction

  2021cites this paper
• Molecular Determinants of the Cardiometabolic Improvements of Dietary Flavanols Identified by an Integrative Analysis of Nutrigenomic Data From a Systematic Review of Animal Studies.

  2021cites this paper
• Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?

  2020cites this paper
• Systematic bioinformatic analysis of nutrigenomic data of flavanols in cell models of cardiometabolic disease.

  2020cites this paper
• Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study

  2020influential citation
• Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention and Treatment of Cardiovascular Diseases: An Updated Review

  2019influential citation
• MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1

  2017cites this paper